Pages that link to "Q51055764"
Jump to navigation
Jump to search
The following pages link to Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo-controlled, double-blind, parallel-group study (Q51055764):
Displaying 6 items.
- Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review. (Q39140474) (← links)
- Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial (Q47185132) (← links)
- Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes. (Q48340758) (← links)
- Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward? (Q57157897) (← links)
- Bidirectional Relationship between Gastric Emptying and Plasma Glucose Control in Normoglycemic Individuals and Diabetic Patients (Q58585434) (← links)
- Incretin-based therapies for patients with type 1 diabetes: a meta-analysis (Q64253654) (← links)